Sign in
Taking peopleNo phase

The Efficacy and Safety of Temporal Interference Stimulation in the Treatment of Post-Traumatic Stress Disorder

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
5 people, planned
Started
8 Jun 2026
Expected to end
Jun 2027
Type of study
Interventional
Treatments tested
  • TI stimulation device (nerviox-1000)
Record updated
12 June 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 18-50 years, male or female
  • Diagnosis of PTSD per DSM-5 (assessed by CAPS-5), with symptom duration of at least 3 months, and PTSD as the current primary diagnosis; comorbid depressive disorder or anxiety disorder is allowed
  • If currently receiving psychiatric medication, the dosage must be stable for at least 4 weeks prior to enrollment
  • At least 9 years of education (junior high school or above)

Who cannot take part

  • Received electroconvulsive therapy (ECT) within the past 6 months
  • Received any other form of neuromodulation within the past 2 months (see Item 3 for ECT)
  • Initiation of structured psychotherapy for PTSD within 3 months prior to screening, with expected change during the 10-week treatment period
  • Any DSM-5 diagnosis other than PTSD, depressive disorder, or anxiety disorder
  • Severe medical illness or any condition that may induce seizures or intracranial hypertension (e.g., cardiovascular or respiratory diseases)
  • History of neurological disorders (e.g., epilepsy, cerebrovascular accident) or brain injury/surgery
  • Presence of intracranial stents, cardiac pacemakers, coronary stents, cochlear implants, or any other MRI-incompatible implants
  • PTSD symptoms too severe to complete required assessments
  • Current significant suicidal behavior risk per investigator judgment
  • Pregnancy or planning to become pregnant during the study period

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the efficacy and safety of Temporal Interference (TI) stimulation in treating patients with post-traumatic stress disorder (PTSD) and to explore its potential neural mechanisms using magnetic resonance imaging (MRI) ,magnetoencephalography(MEG),electroencephalography (EEG).

The group in the trial

  • Bilateral Amygdala Group (BLA-TI)Treatment being tested

    Open-label, single-arm. Participants receive active Temporal Interference (TI) stimulation targeting the bilateral amygdala. Stimulation is delivered twice daily (20 minutes per session) for 7 consecutive days. Parameters: carrier frequencies 2000 Hz and 2160 Hz, envelope frequency 160 Hz, intensity 3-4 mA (adjusted to individual tolerance). Target localization is performed using each participant's MRI data to construct an individualized 3D head model, generating scalp stimulation coordinates for the bilateral amygdala.

    Treatment: TI stimulation device (nerviox-1000)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Fit questions
Built from NCT07644338, who can take part
Record updated
12 June 2026